UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE
13G Under the Securities and Exchange Act of 1934 (Amendment #2) Akoya
Biosciences, Inc.---------------------------------------------------------------
--- (Name of Issuer) Common Stock, par value $0.00001 per share-----------------
------------------------------------------------- (Title of Class of
Securities) 00974H104-----------------------------------------------------------
------- (CUSIP Number) December 31, 2023----------------------------------------
-------------------------- (Date of Event Which Requires Filing of this
Statement)Check the appropriate box to designate the rule pursuant towhich
this Schedule is filed: [X] Rule 13d-1 (b) [ ] Rule 13d-1 (c) [ ] Rule 13d-1
(d)* The remainder of this cover page shall be filled out for areporting
person's initial filing on this form with respect tothe subject class of
securities, and for any subsequent amendmentcontaining information which would
alter the disclosures providedin a prior cover page.The information required
in the remainder of this cover pageshall not be deemed to be "filed" for the
purpose of Section 18of the Securities Exchange Act of 1934 ("Act") or
otherwisesubject to the liabilities of that section of the Act, but shallbe
subject to all other provisions of the Act (however, seethe Notes.)CUSIP NO.
00974H104 13G1 Name of Reporting Person PSC Capital Partners LLC----------------
--------------------------------------------------2 Check the Appropriate Box
if a Member of a Group (a) [ ] (b) [X]--------------------------------------
----------------------------3 SEC Use Only--------------------------------------
----------------------------4 Citizenship or Place of Organization
Delaware------------------------------------------------------------------
Number of 5 Sole Voting Power Shares 3,517,360 shares --------------------------
--------------------- Beneficially 6 Shared Voting Power Owned By 0 Shares
----------------------------------------------- Each 7 Sole Dispositive Power
Reporting 3,517,360 shares -----------------------------------------------
Person 8 Shared Dispositive Power With 0 Shares---------------------------------
---------------------------------9 Aggregate Amount Beneficially Owned by Each
Reporting Person 3,517,360 Shares-----------------------------------------------
-------------------10 Check if the Aggregate Amount in Row (9) Excludes
Certain Shares [X]--------------------------------------------------------------
----11 Percent of Class Represented by Amount in Row (9) 7.2%-------------------
-----------------------------------------------12 Type of Reporting Person
IA------------------------------------------------------------------------------
--------------------------------------------------------------------------------
----------------------------------------CUSIP NO. 00974H104 13G1 Name of
Reporting Person Piper Sandler Companies----------------------------------------
--------------------------2 Check the Appropriate Box if a Member of a Group
(a) [ ] (b) [X]-------------------------------------------------------------
-----3 SEC Use Only-------------------------------------------------------------
-----4 Citizenship or Place of Organization Delaware----------------------------
-------------------------------------- Number of 5 Sole Voting Power Shares
185 shares ----------------------------------------------- Beneficially 6
Shared Voting Power Owned By 19,616 Shares -------------------------------------
---------- Each 7 Sole Dispositive Power Reporting 185 shares ------------------
----------------------------- Person 8 Shared Dispositive Power With 19,616
Shares------------------------------------------------------------------9
Aggregate Amount Beneficially Owned by Each Reporting Person 19,801
Shares------------------------------------------------------------------10
Check if the Aggregate Amount in Row (9) Excludes Certain Shares [X]------------
------------------------------------------------------11 Percent of Class
Represented by Amount in Row (9) Less than 1%-----------------------------------
-------------------------------12 Type of Reporting Person HC-------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
-------------------CUSIP NO. 00974H104 13G1 Name of Reporting Person PJC
Capital LLC------------------------------------------------------------------2
Check the Appropriate Box if a Member of a Group (a) [ ] (b) [X]------------
------------------------------------------------------3 SEC Use Only------------
------------------------------------------------------4 Citizenship or Place
of Organization Delaware--------------------------------------------------------
---------- Number of 5 Sole Voting Power Shares 0 shares -----------------------
------------------------ Beneficially 6 Shared Voting Power Owned By 19,616
Shares ----------------------------------------------- Each 7 Sole Dispositive
Power Reporting 0 shares -----------------------------------------------
Person 8 Shared Dispositive Power With 19,616 Shares----------------------------
--------------------------------------9 Aggregate Amount Beneficially Owned by
Each Reporting Person 19,616 Shares---------------------------------------------
---------------------10 Check if the Aggregate Amount in Row (9) Excludes
Certain Shares [X]--------------------------------------------------------------
----11 Percent of Class Represented by Amount in Row (9) Less than
1%------------------------------------------------------------------12 Type of
Reporting Person HC-------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------Item 1 (a) Name of
Issuer: Akoya Biosciences, Inc.Item 1 (b) Address of Issuer Principal
Executive Offices: 100 Campus Drive, 6th Floor, Marlborough, MA 01752Item 2
(a) Name of Persons Filing: This Schedule 13G is being filed jointly by the
entities identified below (collectively, the Reporting Persons"): * PSC
Capital Partners LLC * Piper Sandler Companies * PJC Capital LLCItem 2 (b)
Address of Principal Business Office: 800 Nicollet Mall Suite 900
Minneapolis, MN 55402 - for all Reporting PersonsItem 2 (c) Citizenship: U.S.
(Delaware) - For all Reporting PersonsItem 2 (d) Title of Class of Securities:
Common Stock, par value $0.00001 per shareItem 2 (e) CUSIP Number:
00974H104Item 3 If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c) of the Securities Exchange Act of 1934 as amended (the
"Exchange Act"), check whether the person filing is a: (a) [ ] Broker or
dealer registered under Section 15 of the Exchange Act; (b) [ ] Bank as
defined in Section 3(a)(19) of the Exchange Act; (c) [ ] Insurance company as
defined in Section 3(a)(19) of the Exchange Act; (d) [ ] Investment company
registered under Section 8 of the Investment Company Act of 1940; (e) [X] An
investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An
employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(
F); (g) [X] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section
3(b) of teh Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church
plan that is excluded from the definition of an investment company under
section 3(c)(14) of the Investment Company Act of 1940; (j) [ ] A non-US
instituition in accordance with Rule 240.13d-1(b)(1)(ii)(J); (k) [ ] A Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S.
institution in accordance with Rule 240.13d-1(b)(ii)(J), please specify the
type of instition.Item 4 Ownership (a) through (c) The information in Items
1 and 5 through 11 on the cover pages to this Schedule 13G are hereby
incorporated by reference. Piper Sandler Companies is the parent corporation
of PSC Capital Partners LLC and PJC Capital LLC (PJC Capital LLC is not a
control person of PSC Capital Partners LLC). As to Piper Sandler Companies and
PSC Capital Partners LLC, this Schedule 13G reflects a disaggregation of
beneficial ownership between the two entities, as defined in Section 13(d) and
13(g) of the Exchange Act. As to Piper Sandler Companies and PJC Capital LLC,
this Schedule 13G reflects that Piper Sandler Companies is deemed to share
voting and dispositive power over the shares held by PJC Capital LLC, in
accordance with Section 13(d) and 13(g) of the Exchange Act and the rules
promulgated thereunder. This Schedule 13G is not an admission that any of
Reporting Persons are the beneficial owner of the securities covered by this
report, except as expressly stated herein, and each of the Reporting Persons
disclaims beneficial ownership of the securities covered by this statement
that are not expressly reported by them as being beneficially owned, pursuant
to Exchange Act Rule 13d-4.Item 5 Ownership of Five Percent or Less of a
Class: Not applicable.Item 6 Ownership of More than Five Percent on Behalf of
Another Person: Not applicable.Item 7 Identification and Classification of
the Subsidiary Which Acquired the Security being Reported on by the Parent
Holding Company: Not applicable.Item 8 Identification and Classification of
Members of the Group: Not applicable.Item 9 Notice of Dissolution of the
Group: Not applicable.Item 10 Certification By signing below I certify that,
to the best of my knowledge and belief, the securities referred to above were
acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not acquired
and are not held in connection with or as a participant in any transaction
having such purposes or effect. List of Exhibits Exhibit 99.1 Joint Filing
Agreement - filed herewith SIGNATURE After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in
this statement is true, complete and correct. PSC CAPITAL PARTNERS LLC
Date: 2/12/23 By /s/ Theodore J. Christianson ----------------------------
------ Signature Name/Title Theodore J. Christianson, CEO PIPER
SANDLER COMPANIES Date: 2/12/23 By /s/ Katherine P. Clune
---------------------------------- Signature Name/Title Katherine P.
Clune, CFO PJC CAPITAL LLC Date: 2/12/23 By /s/ Katherine P. Clune
---------------------------------- Signature Name/Title Katherine P.
Clune, CFO